Return On Equity in % of BriaCell Therapeutics Corp. from Q1 2023 to Q2 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BriaCell Therapeutics Corp. quarterly/annual Return On Equity history and change rate from Q1 2023 to Q2 2025.
  • BriaCell Therapeutics Corp. Return On Equity for the quarter ending 31 Jul 2025 was -291 %, a 323% decline year-over-year.
  • BriaCell Therapeutics Corp. annual Return On Equity for 2025 was -291 %, a 323% decline from 2024.
  • BriaCell Therapeutics Corp. annual Return On Equity for 2024 was 130 %, a 99% decline from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

BriaCell Therapeutics Corp. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -291 -421 -323% 01 May 2025 31 Jul 2025
Q1 2025 -480 -632 -416% 01 Feb 2025 30 Apr 2025
Q4 2024 2.34K +2.02K +619% 01 Nov 2024 31 Jan 2025
Q3 2024 491 -135 -21.6% 01 Aug 2024 31 Oct 2024
Q2 2024 130 -13.1K -99% 01 May 2024 31 Jul 2024
Q1 2024 152 +695 01 Feb 2024 30 Apr 2024
Q4 2023 326 01 Nov 2023 31 Jan 2024
Q3 2023 626 01 Aug 2023 31 Oct 2023
Q2 2023 13.2K 01 May 2023 31 Jul 2023
Q1 2023 -544 01 Feb 2023 30 Apr 2023

BriaCell Therapeutics Corp. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -291 -421 -323% 01 Aug 2024 31 Jul 2025
2024 130 -13.1K -99% 01 Aug 2023 31 Jul 2024
2023 13.2K 01 Aug 2022 31 Jul 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.